Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Piroxicam market report explains the definition, types, applications, major countries, and major players of the Piroxicam market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Bayer
Genpharm
Changzhou Siyao Pharmaceutical
JINGHUA
Keltman Pharmaceuticals
Mylan
JUMPCAN
Chiesi
Pfizer
Teva
FANGMING
SK Chemicals
PLX Pharma
APR
CJ HealthCare
DCPC
SkyePharma
Technilab Pharma
Shanxi Yunpeng Pharmaceutical
Nostrum
Apotex Corporation
Bioglan Laboratories
By Type:
by Dosage Form
Suppositories
Injection
Capsule
Patch
Other
by Route
Oral
Rectal
By End-User:
Tendonitis
Systemic Traumatic Pain
Musculoskeletal Pain
Contraception
Rheumatoid Arthritis
Chronic Infectious Arthritis
Osteoarthritis
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Piroxicam Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Piroxicam Outlook to 2028- Original Forecasts
-
2.2 Piroxicam Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Piroxicam Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Piroxicam Market- Recent Developments
-
6.1 Piroxicam Market News and Developments
-
6.2 Piroxicam Market Deals Landscape
7 Piroxicam Raw Materials and Cost Structure Analysis
-
7.1 Piroxicam Key Raw Materials
-
7.2 Piroxicam Price Trend of Key Raw Materials
-
7.3 Piroxicam Key Suppliers of Raw Materials
-
7.4 Piroxicam Market Concentration Rate of Raw Materials
-
7.5 Piroxicam Cost Structure Analysis
-
7.5.1 Piroxicam Raw Materials Analysis
-
7.5.2 Piroxicam Labor Cost Analysis
-
7.5.3 Piroxicam Manufacturing Expenses Analysis
8 Global Piroxicam Import and Export Analysis (Top 10 Countries)
-
8.1 Global Piroxicam Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Piroxicam Export by Region (Top 10 Countries) (2017-2028)
9 Global Piroxicam Market Outlook by Types and Applications to 2022
-
9.1 Global Piroxicam Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global by Dosage Form Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Suppositories Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Injection Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Capsule Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Patch Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Other Consumption and Growth Rate (2017-2022)
-
9.1.7 Global by Route Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.9 Global Rectal Consumption and Growth Rate (2017-2022)
-
9.2 Global Piroxicam Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Tendonitis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Systemic Traumatic Pain Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Musculoskeletal Pain Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Contraception Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Chronic Infectious Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Osteoarthritis Consumption and Growth Rate (2017-2022)
-
9.2.8 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Piroxicam Market Analysis and Outlook till 2022
-
10.1 Global Piroxicam Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Piroxicam Consumption (2017-2022)
-
10.2.2 Canada Piroxicam Consumption (2017-2022)
-
10.2.3 Mexico Piroxicam Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Piroxicam Consumption (2017-2022)
-
10.3.2 UK Piroxicam Consumption (2017-2022)
-
10.3.3 Spain Piroxicam Consumption (2017-2022)
-
10.3.4 Belgium Piroxicam Consumption (2017-2022)
-
10.3.5 France Piroxicam Consumption (2017-2022)
-
10.3.6 Italy Piroxicam Consumption (2017-2022)
-
10.3.7 Denmark Piroxicam Consumption (2017-2022)
-
10.3.8 Finland Piroxicam Consumption (2017-2022)
-
10.3.9 Norway Piroxicam Consumption (2017-2022)
-
10.3.10 Sweden Piroxicam Consumption (2017-2022)
-
10.3.11 Poland Piroxicam Consumption (2017-2022)
-
10.3.12 Russia Piroxicam Consumption (2017-2022)
-
10.3.13 Turkey Piroxicam Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Piroxicam Consumption (2017-2022)
-
10.4.2 Japan Piroxicam Consumption (2017-2022)
-
10.4.3 India Piroxicam Consumption (2017-2022)
-
10.4.4 South Korea Piroxicam Consumption (2017-2022)
-
10.4.5 Pakistan Piroxicam Consumption (2017-2022)
-
10.4.6 Bangladesh Piroxicam Consumption (2017-2022)
-
10.4.7 Indonesia Piroxicam Consumption (2017-2022)
-
10.4.8 Thailand Piroxicam Consumption (2017-2022)
-
10.4.9 Singapore Piroxicam Consumption (2017-2022)
-
10.4.10 Malaysia Piroxicam Consumption (2017-2022)
-
10.4.11 Philippines Piroxicam Consumption (2017-2022)
-
10.4.12 Vietnam Piroxicam Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Piroxicam Consumption (2017-2022)
-
10.5.2 Colombia Piroxicam Consumption (2017-2022)
-
10.5.3 Chile Piroxicam Consumption (2017-2022)
-
10.5.4 Argentina Piroxicam Consumption (2017-2022)
-
10.5.5 Venezuela Piroxicam Consumption (2017-2022)
-
10.5.6 Peru Piroxicam Consumption (2017-2022)
-
10.5.7 Puerto Rico Piroxicam Consumption (2017-2022)
-
10.5.8 Ecuador Piroxicam Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Piroxicam Consumption (2017-2022)
-
10.6.2 Kuwait Piroxicam Consumption (2017-2022)
-
10.6.3 Oman Piroxicam Consumption (2017-2022)
-
10.6.4 Qatar Piroxicam Consumption (2017-2022)
-
10.6.5 Saudi Arabia Piroxicam Consumption (2017-2022)
-
10.6.6 United Arab Emirates Piroxicam Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Piroxicam Consumption (2017-2022)
-
10.7.2 South Africa Piroxicam Consumption (2017-2022)
-
10.7.3 Egypt Piroxicam Consumption (2017-2022)
-
10.7.4 Algeria Piroxicam Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Piroxicam Consumption (2017-2022)
-
10.8.2 New Zealand Piroxicam Consumption (2017-2022)
11 Global Piroxicam Competitive Analysis
-
11.1 Bayer
-
11.1.1 Bayer Company Details
-
11.1.2 Bayer Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Bayer Piroxicam Main Business and Markets Served
-
11.1.4 Bayer Piroxicam Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Genpharm
-
11.2.1 Genpharm Company Details
-
11.2.2 Genpharm Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Genpharm Piroxicam Main Business and Markets Served
-
11.2.4 Genpharm Piroxicam Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Changzhou Siyao Pharmaceutical
-
11.3.1 Changzhou Siyao Pharmaceutical Company Details
-
11.3.2 Changzhou Siyao Pharmaceutical Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Changzhou Siyao Pharmaceutical Piroxicam Main Business and Markets Served
-
11.3.4 Changzhou Siyao Pharmaceutical Piroxicam Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 JINGHUA
-
11.4.1 JINGHUA Company Details
-
11.4.2 JINGHUA Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 JINGHUA Piroxicam Main Business and Markets Served
-
11.4.4 JINGHUA Piroxicam Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Keltman Pharmaceuticals
-
11.5.1 Keltman Pharmaceuticals Company Details
-
11.5.2 Keltman Pharmaceuticals Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Keltman Pharmaceuticals Piroxicam Main Business and Markets Served
-
11.5.4 Keltman Pharmaceuticals Piroxicam Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Mylan
-
11.6.1 Mylan Company Details
-
11.6.2 Mylan Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Mylan Piroxicam Main Business and Markets Served
-
11.6.4 Mylan Piroxicam Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 JUMPCAN
-
11.7.1 JUMPCAN Company Details
-
11.7.2 JUMPCAN Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 JUMPCAN Piroxicam Main Business and Markets Served
-
11.7.4 JUMPCAN Piroxicam Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Chiesi
-
11.8.1 Chiesi Company Details
-
11.8.2 Chiesi Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Chiesi Piroxicam Main Business and Markets Served
-
11.8.4 Chiesi Piroxicam Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Pfizer
-
11.9.1 Pfizer Company Details
-
11.9.2 Pfizer Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Pfizer Piroxicam Main Business and Markets Served
-
11.9.4 Pfizer Piroxicam Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Teva
-
11.10.1 Teva Company Details
-
11.10.2 Teva Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Teva Piroxicam Main Business and Markets Served
-
11.10.4 Teva Piroxicam Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 FANGMING
-
11.11.1 FANGMING Company Details
-
11.11.2 FANGMING Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 FANGMING Piroxicam Main Business and Markets Served
-
11.11.4 FANGMING Piroxicam Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 SK Chemicals
-
11.12.1 SK Chemicals Company Details
-
11.12.2 SK Chemicals Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 SK Chemicals Piroxicam Main Business and Markets Served
-
11.12.4 SK Chemicals Piroxicam Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 PLX Pharma
-
11.13.1 PLX Pharma Company Details
-
11.13.2 PLX Pharma Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 PLX Pharma Piroxicam Main Business and Markets Served
-
11.13.4 PLX Pharma Piroxicam Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 APR
-
11.14.1 APR Company Details
-
11.14.2 APR Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 APR Piroxicam Main Business and Markets Served
-
11.14.4 APR Piroxicam Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 CJ HealthCare
-
11.15.1 CJ HealthCare Company Details
-
11.15.2 CJ HealthCare Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 CJ HealthCare Piroxicam Main Business and Markets Served
-
11.15.4 CJ HealthCare Piroxicam Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 DCPC
-
11.16.1 DCPC Company Details
-
11.16.2 DCPC Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 DCPC Piroxicam Main Business and Markets Served
-
11.16.4 DCPC Piroxicam Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 SkyePharma
-
11.17.1 SkyePharma Company Details
-
11.17.2 SkyePharma Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 SkyePharma Piroxicam Main Business and Markets Served
-
11.17.4 SkyePharma Piroxicam Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Technilab Pharma
-
11.18.1 Technilab Pharma Company Details
-
11.18.2 Technilab Pharma Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Technilab Pharma Piroxicam Main Business and Markets Served
-
11.18.4 Technilab Pharma Piroxicam Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Shanxi Yunpeng Pharmaceutical
-
11.19.1 Shanxi Yunpeng Pharmaceutical Company Details
-
11.19.2 Shanxi Yunpeng Pharmaceutical Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Shanxi Yunpeng Pharmaceutical Piroxicam Main Business and Markets Served
-
11.19.4 Shanxi Yunpeng Pharmaceutical Piroxicam Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Nostrum
-
11.20.1 Nostrum Company Details
-
11.20.2 Nostrum Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Nostrum Piroxicam Main Business and Markets Served
-
11.20.4 Nostrum Piroxicam Product Portfolio
-
11.20.5 Recent Research and Development Strategies
-
11.21 Apotex Corporation
-
11.21.1 Apotex Corporation Company Details
-
11.21.2 Apotex Corporation Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
11.21.3 Apotex Corporation Piroxicam Main Business and Markets Served
-
11.21.4 Apotex Corporation Piroxicam Product Portfolio
-
11.21.5 Recent Research and Development Strategies
-
11.22 Bioglan Laboratories
-
11.22.1 Bioglan Laboratories Company Details
-
11.22.2 Bioglan Laboratories Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
11.22.3 Bioglan Laboratories Piroxicam Main Business and Markets Served
-
11.22.4 Bioglan Laboratories Piroxicam Product Portfolio
-
11.22.5 Recent Research and Development Strategies
12 Global Piroxicam Market Outlook by Types and Applications to 2028
-
12.1 Global Piroxicam Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global by Dosage Form Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Suppositories Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Capsule Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Patch Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
12.1.7 Global by Route Consumption Forecast and Growth Rate (2022-2028)
-
12.1.8 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
12.1.9 Global Rectal Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Piroxicam Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Tendonitis Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Systemic Traumatic Pain Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Musculoskeletal Pain Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Contraception Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
12.2.6 Global Chronic Infectious Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
12.2.7 Global Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)
-
12.2.8 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Piroxicam Market Analysis and Outlook to 2028
-
13.1 Global Piroxicam Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Piroxicam Consumption Forecast (2022-2028)
-
13.2.2 Canada Piroxicam Consumption Forecast (2022-2028)
-
13.2.3 Mexico Piroxicam Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Piroxicam Consumption Forecast (2022-2028)
-
13.3.2 UK Piroxicam Consumption Forecast (2022-2028)
-
13.3.3 Spain Piroxicam Consumption Forecast (2022-2028)
-
13.3.4 Belgium Piroxicam Consumption Forecast (2022-2028)
-
13.3.5 France Piroxicam Consumption Forecast (2022-2028)
-
13.3.6 Italy Piroxicam Consumption Forecast (2022-2028)
-
13.3.7 Denmark Piroxicam Consumption Forecast (2022-2028)
-
13.3.8 Finland Piroxicam Consumption Forecast (2022-2028)
-
13.3.9 Norway Piroxicam Consumption Forecast (2022-2028)
-
13.3.10 Sweden Piroxicam Consumption Forecast (2022-2028)
-
13.3.11 Poland Piroxicam Consumption Forecast (2022-2028)
-
13.3.12 Russia Piroxicam Consumption Forecast (2022-2028)
-
13.3.13 Turkey Piroxicam Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Piroxicam Consumption Forecast (2022-2028)
-
13.4.2 Japan Piroxicam Consumption Forecast (2022-2028)
-
13.4.3 India Piroxicam Consumption Forecast (2022-2028)
-
13.4.4 South Korea Piroxicam Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Piroxicam Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Piroxicam Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Piroxicam Consumption Forecast (2022-2028)
-
13.4.8 Thailand Piroxicam Consumption Forecast (2022-2028)
-
13.4.9 Singapore Piroxicam Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Piroxicam Consumption Forecast (2022-2028)
-
13.4.11 Philippines Piroxicam Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Piroxicam Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Piroxicam Consumption Forecast (2022-2028)
-
13.5.2 Colombia Piroxicam Consumption Forecast (2022-2028)
-
13.5.3 Chile Piroxicam Consumption Forecast (2022-2028)
-
13.5.4 Argentina Piroxicam Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Piroxicam Consumption Forecast (2022-2028)
-
13.5.6 Peru Piroxicam Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Piroxicam Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Piroxicam Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Piroxicam Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Piroxicam Consumption Forecast (2022-2028)
-
13.6.3 Oman Piroxicam Consumption Forecast (2022-2028)
-
13.6.4 Qatar Piroxicam Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Piroxicam Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Piroxicam Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Piroxicam Consumption Forecast (2022-2028)
-
13.7.2 South Africa Piroxicam Consumption Forecast (2022-2028)
-
13.7.3 Egypt Piroxicam Consumption Forecast (2022-2028)
-
13.7.4 Algeria Piroxicam Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Piroxicam Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Piroxicam Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Piroxicam
-
Figure of Piroxicam Picture
-
Table Global Piroxicam Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Piroxicam Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global by Dosage Form Consumption and Growth Rate (2017-2022)
-
Figure Global Suppositories Consumption and Growth Rate (2017-2022)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Capsule Consumption and Growth Rate (2017-2022)
-
Figure Global Patch Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global by Route Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Rectal Consumption and Growth Rate (2017-2022)
-
Figure Global Tendonitis Consumption and Growth Rate (2017-2022)
-
Figure Global Systemic Traumatic Pain Consumption and Growth Rate (2017-2022)
-
Figure Global Musculoskeletal Pain Consumption and Growth Rate (2017-2022)
-
Figure Global Contraception Consumption and Growth Rate (2017-2022)
-
Figure Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Infectious Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Osteoarthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Piroxicam Consumption by Country (2017-2022)
-
Table North America Piroxicam Consumption by Country (2017-2022)
-
Figure United States Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Canada Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Mexico Piroxicam Consumption and Growth Rate (2017-2022)
-
Table Europe Piroxicam Consumption by Country (2017-2022)
-
Figure Germany Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure UK Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Spain Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Belgium Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure France Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Italy Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Denmark Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Finland Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Norway Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Sweden Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Poland Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Russia Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Turkey Piroxicam Consumption and Growth Rate (2017-2022)
-
Table APAC Piroxicam Consumption by Country (2017-2022)
-
Figure China Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Japan Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure India Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure South Korea Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Thailand Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Singapore Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Philippines Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Piroxicam Consumption and Growth Rate (2017-2022)
-
Table South America Piroxicam Consumption by Country (2017-2022)
-
Figure Brazil Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Colombia Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Chile Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Argentina Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Peru Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Piroxicam Consumption and Growth Rate (2017-2022)
-
Table GCC Piroxicam Consumption by Country (2017-2022)
-
Figure Bahrain Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Oman Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Qatar Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Piroxicam Consumption and Growth Rate (2017-2022)
-
Table Africa Piroxicam Consumption by Country (2017-2022)
-
Figure Nigeria Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure South Africa Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Egypt Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure Algeria Piroxicam Consumption and Growth Rate (2017-2022)
-
Table Oceania Piroxicam Consumption by Country (2017-2022)
-
Figure Australia Piroxicam Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Piroxicam Consumption and Growth Rate (2017-2022)
-
Table Bayer Company Details
-
Table Bayer Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Piroxicam Main Business and Markets Served
-
Table Bayer Piroxicam Product Portfolio
-
Table Genpharm Company Details
-
Table Genpharm Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genpharm Piroxicam Main Business and Markets Served
-
Table Genpharm Piroxicam Product Portfolio
-
Table Changzhou Siyao Pharmaceutical Company Details
-
Table Changzhou Siyao Pharmaceutical Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
Table Changzhou Siyao Pharmaceutical Piroxicam Main Business and Markets Served
-
Table Changzhou Siyao Pharmaceutical Piroxicam Product Portfolio
-
Table JINGHUA Company Details
-
Table JINGHUA Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
Table JINGHUA Piroxicam Main Business and Markets Served
-
Table JINGHUA Piroxicam Product Portfolio
-
Table Keltman Pharmaceuticals Company Details
-
Table Keltman Pharmaceuticals Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
Table Keltman Pharmaceuticals Piroxicam Main Business and Markets Served
-
Table Keltman Pharmaceuticals Piroxicam Product Portfolio
-
Table Mylan Company Details
-
Table Mylan Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Piroxicam Main Business and Markets Served
-
Table Mylan Piroxicam Product Portfolio
-
Table JUMPCAN Company Details
-
Table JUMPCAN Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
Table JUMPCAN Piroxicam Main Business and Markets Served
-
Table JUMPCAN Piroxicam Product Portfolio
-
Table Chiesi Company Details
-
Table Chiesi Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chiesi Piroxicam Main Business and Markets Served
-
Table Chiesi Piroxicam Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Piroxicam Main Business and Markets Served
-
Table Pfizer Piroxicam Product Portfolio
-
Table Teva Company Details
-
Table Teva Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Piroxicam Main Business and Markets Served
-
Table Teva Piroxicam Product Portfolio
-
Table FANGMING Company Details
-
Table FANGMING Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
Table FANGMING Piroxicam Main Business and Markets Served
-
Table FANGMING Piroxicam Product Portfolio
-
Table SK Chemicals Company Details
-
Table SK Chemicals Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
Table SK Chemicals Piroxicam Main Business and Markets Served
-
Table SK Chemicals Piroxicam Product Portfolio
-
Table PLX Pharma Company Details
-
Table PLX Pharma Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
Table PLX Pharma Piroxicam Main Business and Markets Served
-
Table PLX Pharma Piroxicam Product Portfolio
-
Table APR Company Details
-
Table APR Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
Table APR Piroxicam Main Business and Markets Served
-
Table APR Piroxicam Product Portfolio
-
Table CJ HealthCare Company Details
-
Table CJ HealthCare Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
Table CJ HealthCare Piroxicam Main Business and Markets Served
-
Table CJ HealthCare Piroxicam Product Portfolio
-
Table DCPC Company Details
-
Table DCPC Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
Table DCPC Piroxicam Main Business and Markets Served
-
Table DCPC Piroxicam Product Portfolio
-
Table SkyePharma Company Details
-
Table SkyePharma Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
Table SkyePharma Piroxicam Main Business and Markets Served
-
Table SkyePharma Piroxicam Product Portfolio
-
Table Technilab Pharma Company Details
-
Table Technilab Pharma Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
Table Technilab Pharma Piroxicam Main Business and Markets Served
-
Table Technilab Pharma Piroxicam Product Portfolio
-
Table Shanxi Yunpeng Pharmaceutical Company Details
-
Table Shanxi Yunpeng Pharmaceutical Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shanxi Yunpeng Pharmaceutical Piroxicam Main Business and Markets Served
-
Table Shanxi Yunpeng Pharmaceutical Piroxicam Product Portfolio
-
Table Nostrum Company Details
-
Table Nostrum Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nostrum Piroxicam Main Business and Markets Served
-
Table Nostrum Piroxicam Product Portfolio
-
Table Apotex Corporation Company Details
-
Table Apotex Corporation Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
Table Apotex Corporation Piroxicam Main Business and Markets Served
-
Table Apotex Corporation Piroxicam Product Portfolio
-
Table Bioglan Laboratories Company Details
-
Table Bioglan Laboratories Piroxicam Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bioglan Laboratories Piroxicam Main Business and Markets Served
-
Table Bioglan Laboratories Piroxicam Product Portfolio
-
Figure Global by Dosage Form Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Suppositories Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Capsule Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Patch Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global by Route Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rectal Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tendonitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Systemic Traumatic Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Musculoskeletal Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Contraception Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Infectious Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Piroxicam Consumption Forecast by Country (2022-2028)
-
Table North America Piroxicam Consumption Forecast by Country (2022-2028)
-
Figure United States Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Piroxicam Consumption Forecast by Country (2022-2028)
-
Figure Germany Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Piroxicam Consumption Forecast by Country (2022-2028)
-
Figure China Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Piroxicam Consumption Forecast by Country (2022-2028)
-
Figure Brazil Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Piroxicam Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Piroxicam Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Piroxicam Consumption Forecast by Country (2022-2028)
-
Figure Australia Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Piroxicam Consumption Forecast and Growth Rate (2022-2028)
-
